Verteporfin‐Loaded Bioadhesive Nanoparticles for the Prevention of Hypertrophic Scar
Small Methods · 2024
DOI: 10.1002/smtd.202301295 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, 2024. Verfasst von Peng Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Burn and Wound Repair Surgery, The First Affiliated Hospital of Sun Yat-senUniversity, No.58, Zhongshan 2nd Road, Guangzhou, 510080, Ch…. Hauptthemen laut MEDLINE: Cicatrix, Hypertrophic, Nanoparticles, Verteporfin, Fibroblasts. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Ke lin New-star Plan of the First Affiliated Hospital of.
Abstract (Originalsprache)
Hypertrophic scarring (HS) is a common skin injury complication with unmet needs. Verteporfin (VP) should be an ideal HS‐targeted therapeutic drug due to its efficient fibrosis and angiogenesis inhibitory abilities. However, its application is restricted by its side effects such as dose‐dependent cytotoxicity on normal cells. Herein, the bioadhesive nanoparticles encapsulated VP (VP/BNPs) are successfully developed to attenuate the side effects of VP and enhance its HS inhibition effects by limiting VP releasing slowly and stably in the lesion site but not diffusing easily to normal tissues. VP/BNPs displayed significant inhibition on the proliferation, migration, collagen deposition, and vessel formation of human hypertrophic scar fibroblasts (HSFBs) and dermal vascular endothelial cells (HDVECs). In a rat tail HS model, VP/BNPs treated HS exhibits dramatic scar repression with almost no side effects compared with free VP or VP‐loaded non‐bioadhesive nanoparticles (VP/NNPs) administration. Further immunofluorescence analysis on scar tissue serial sections validated VP/BNPs effectively inhibited the collagen deposition and angiogenesis by firmly confined in the scar tissue and persistently releasing VP targeted to nucleus Yes‐associated protein (nYAP) of HSFBs and HDVECs. These findings collectively suggest that VP/BNPs can be a promising and technically advantageous agent for HS therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Burn and Wound Repair Surgery, The First Affiliated Hospital of Sun Yat-senUniversity, No.58, Zhongshan 2nd Road, Guangzhou, 510080, China.
- Department of School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, No.66, Gongchang Road, Shenzhen, 518107, China.
- Department of Translational medicine research institute, First People's Hospital of Foshan, No. 81, North Lingnan Road, Foshan, Guangdong, 528000, China.
ORCID-Profile: Peng Wang, Zhangwen Peng, Liu Yu, Yiling Liu, Hanwen Wang, Ziheng Zhou, Hengdeng Liu, Sheng Hong, Yichu Nie, Yang Deng, Yang Liu, Julin Xie
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Ke lin New-star Plan of the First Affiliated Hospital of
- Sun Yat-sen University
- Fundamental Research Funds for the Central Universities
- Guangdong Province "Pearl River" Young Talent Support Program
- Shenzhen Science and Technology Program
Zitieren
APA
Wang, P., Peng, Z., Yu, L., Liu, Y., Wang, H., Zhou, Z., Liu, H., Hong, S., Nie, Y., Deng, Y., Liu, Y., & Xie, J. (2024). Verteporfin‐Loaded Bioadhesive Nanoparticles for the Prevention of Hypertrophic Scar. Small Methods. https://doi.org/10.1002/smtd.202301295
Vancouver
Wang P, Peng Z, Yu L, Liu Y, Wang H, Zhou Z, et al. Verteporfin‐Loaded Bioadhesive Nanoparticles for the Prevention of Hypertrophic Scar. Small Methods. 2024. doi:10.1002/smtd.202301295
BibTeX
@article{Wang2024,
author = {Wang, Peng and Peng, Zhangwen and Yu, Liu and Liu, Yiling and Wang, Hanwen and Zhou, Ziheng and Liu, Hengdeng and Hong, Sheng and Nie, Yichu and Deng, Yang and Liu, Yang and Xie, Julin},
title = {Verteporfin‐Loaded Bioadhesive Nanoparticles for the Prevention of Hypertrophic Scar},
journal = {Small Methods},
year = {2024},
doi = {10.1002/smtd.202301295}
}
EUVIMED